Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro

BACKGROUND: Coronavirus disease 2019 (COVID-19) causes a global pandemic and has devastating effects around the world, however, there are no specific antiviral drugs and vaccines for the constant mutation of SARS-CoV-2. PURPOSE: In this study, we evaluted the antiviral and anti-inflammatory activiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Qinhai, Lei, Biao, Chen, Ruihan, Liu, Bin, Lu, Wencong, Jiang, Haiming, Chen, Zexing, Guo, Xiaowen, Wang, Yutao, Zhang, Lu, Chen, Qiaoyan, Li, Xiaobo, Yang, Zifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972667/
https://www.ncbi.nlm.nih.gov/pubmed/35365215
http://dx.doi.org/10.1186/s13020-022-00598-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972667/
https://www.ncbi.nlm.nih.gov/pubmed/35365215
http://dx.doi.org/10.1186/s13020-022-00598-4

Ejemplares similares